T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Industry Outlook

T-cell lymphoma treatment market accounted for a market value of US$ 1,164.6 Mn in 2020 and projected to grow at a CAGR of 11.7% during the forecast period from 2021 to 2029. Lymphoma is divided into two types Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphoma is segmented as B-cell lymphoma and T-cell lymphoma, B-cell lymphoma accounted nearly 85% of the lymphoma diagnoses and remaining 15% being T-cell lymphoma. T-cell lymphoma is considered as the most complex lymphoma which makes it very difficult to diagnose. However, developing diagnostic technologies and incessant research and development in the field of T-cell lymphoma treatment is expected to assist the growth of this market throughout the forecast period. On 16th November 2021, FDA approved first-line treatment for peripheral T-cell lymphoma named Adcertis (brentuximab vedotin) in combination with chemotherapy for adult patients with specific types of peripheral T-cell lymphoma (PTCL). Brentuximab vedotin is a monoclonal antibody that binds to a protein (called CD30) identified on some cancer cells. Thus, such novel drug therapies entering in the T-cell lymphoma treatment market expected to drive the overall growth of the market throughout the forecast period from 2021 to 2029.

Peripheral T-cell lymphoma expected to be the fastest growing T-cell lymphoma treatment market

According to Premera Blue Cross, the projected annual incidence of CTCL is 0.4 to 1 case per 100,000 (or 1,000 to 3,000 new cases per year) in the United States. However, mortality rate of CTCL is not high and patients can live with CTCL around 10 or more. The average estimated prevalence of CTCL in the U.S. is approximately 20,000. Thus, this makes CTCL most prevalent type of t-cell lymphoma providing it overall market share of 32% in T-cell lymphoma treatment market for year 2020. However, promising pipeline and recent drug approvals such as Adcertis makes PTCL one of the fastest growing T-cell lymphoma type market throughout the forecast period from 2021 to 2029.

North America identified as the largest and fastest growing T-cell lymphoma treatment market due to introduction of novel therapies & high prevalence rate of T-cell lymphoma

North America will maintain its dominance throughout the forecast period in T-cell lymphoma treatment market due to key driving factors such as rising prevalence & awareness related to T-cell lymphoma, promising drug pipeline & upcoming drug launches, and increasing demand for target-specific & safe drugs. According to cutaneous lymphoma foundation, CTCL is a rare disease with around 3,000 new cases recorded in the United States each year. CTCL found usually in men compared to women and specifically in patients aged above 50 years.

Historical & Forecast Period

The T-cell lymphoma treatment market analyzed considering current market trends for base year 2020 and based on future trends CAGRs calculated for the forecast period from 2021 to 2029.The key players present in the market analyzed based on product portfolio, financial information, recent market updates, and key market strategies. This report also comprises attractive investment proposition analyzed with the help of exhaustive geographical research based on PESTEL analysis. Key players profiled in the report include Actelion Pharmaceuticals, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Celgene Corporation, Seattle Genetics, Shenzen ChipScreen Biosciences, Ltd., Genmab A/S, Medivir AB, Amgen, Inc., Eisai, Inc., F. Hoffman La-Roche, and Sorrento Therapeutics, Inc., among others.

Key questions answered in this report

• Which is the trending drug type in the market preferred against T-cell lymphoma & Why?
• What are the current market strategies followed by key players & competitive analysis specific to T-cell lymphoma treatment market?
• Which are the key geographical markets (regions and countries) in T-cell lymphoma treatment market?
• Which is the largest and fastest growing T-cell lymphoma types globally?
• How is the competition in T-cell lymphoma treatment market and strategies of key players functioning in this industry?

This product will be delivered within 2 business days.